AKT1 and pancreatic neoplasm: In the present study, we investigated the hypothesis that inhibition of activated AKT promotes gemcitabine-induced apoptosis and confers gemcitabine sensitivity in cultured pancreatic cancer cells, in part, by PUMA upregulation.